 | |||||
| lose weight | |||||
| NEWS | |||||
| Retail investors buy Novo dip after disappointing weight-loss drug data - Reuters U.S. retail investor fund flows into Novo Nordisk surged 32-fold on Friday, as the Danish drugmaker's weaker-than-expected obesity drug data ...
| |||||
| See more results | Edit this alert | |||||
| You have received this email because you have subscribed to Google Alerts. |
 Receive this alert as RSS feed |
| Send Feedback |
